Professor Hamburg University, Germany
Professor Politechnic University Madrid, Spain
Group Leader Max Planck Institute Potsdam, Germany
Professor of Medical Microbiology and Immunology/Bacteriology at the University of Wisconsin, Editor of Fungal Biology and Genetics, American Phytopathological Society Fellow and American Academy of Microbiology Fellow
Dr. Mather A Khan is a Senior Scientist at the Institute of Botanik, Heinrich Heine University, Düsseldorf, Germany. Before moving to Germany, Dr. Khan worked as a Postdoctoral fellow and then as a Research Scientist at the University of Missouri-Columbia, USA.
Dr. Khan’s research interest is mainly focused on understanding the mechanisms mediating the uptake and accumulation of essential (Iron, Fe; Zinc, Zn) and toxic metals (Cadmium, Cd) in plants. He is using state-of-the-art techniques including cell-specific transcriptomics, functional genomics, and ionomics to understand how plants take up, distribute and accumulate micronutrients and toxic elements within plant tissues, including seeds. During his stay at the University of Missouri, Dr. Khan discovered that leaves seem to sense the Fe status of the whole plant before roots that in contrast to the traditional view of nutrient sensing by plant roots. His research suggests that leaves integrate signals from different tissues and relay the information on the Fe status to roots to trigger, or not, an Fe deficiency response (i.e. increased Fe uptake).
He joined the Institute of Botanik, Heinrich Heine University in January 2021, where his research continues to explore the seed loading mechanism of Fe and Zn and develop strategies to optimize crops for higher protein and nutritional value which are essential for future agriculture production to ensure food security and reduce malnutrition and poverty.
I received my MSc. Degree from Jawaharlal Nehru University, India in 2007 on understanding the role of TBP associated factor 9 (TAF9) in eukaryotic transcription. I completed my Ph.D. training in the laboratory of Prof. Paturu Kondaiah, in 2012, at Indian Institute of Science, Bangalore, India, on exploring the mechanism of precancerous oral lesion (OSF and Oral cancer) using gene expression profiling. I also worked on exploring the molecular mechanism of photo dynamic therapy agents in cancer cells. I did my first post doctorate in Dr. Praveen Arany’s lab at NIDCR, NIH on exploring the role of laser mediated phototoxicity involving ER stress and laser mediated wound healing. I am currently doing my second postdoctoral training in the laboratory of Patricia Steeg at NCI in NIH, on exploring the molecular mechanism of metastasis suppressor gene, NM23 in breast cancer metastasis and its possible therapeutic applications.
Distinguished Professor of Biochemistry at College of Science, King Saud University, Riyadh, Saudi Arabia. Group Leader of Analytical and Molecular Bioscience Research Group and a Chair Professor at Research Chair for Biomedical Applications of Nanomaterials, King Saud University. PhD from Aligarh Muslim University, Aligarh, India and received scientific trainings in USA, UK, Denmark and Finland. Fellow of the Royal College of Pathologists (FRCPath) and the Royal Society of Chemistry (FRSC), UK. Authored more than 300 publications including 2 books and 20 book chapters. Recipient of Microsoft eScience Award. Listed in Top-2% World Ranking of Scientists. Research interests are clinical biochemistry, analytical chemistry, environmental chemistry, nanobiotechnology, molecular conservation, bioinformatics, pharmacology, and toxicology.
Dr. Mohammed Kuddus is working as a Professor and Chairman of Biochemistry Department at University of Hail, Saudi Arabia. His main research area includes Molecular biology, Industrial enzymes, Extremophiles and Extremozymes, Microbial biotechnology, Food biotechnology, Waste utilization, Value added products, Bioremediation, Biopolymers and Bioplastics. He has published more than 75 research articles in reputed international journals along with 8 books and 22 book chapters; and presented more than 40 abstracts in national/international conferences/symposia. He has been serving as an Editor / Editorial Board Member and Reviewer of various international reputed journals. He has been awarded Young Scientist Projects from the Department of Science and Technology, India and International Foundation for Science, Sweden.
Genetics, Genomics, Bioinformatics, Corn, Tomato, Soybean, Wheat-Rye Translocation
I study bacterial pathogenesis, focusing on autotransporters of Gram-negative bacteria. These proteins are self-contained secretion systems and surface molecules that mediate a number of virulence functions. I aim to understand three aspects of autotransporter-mediated pathogenesis: 1) the mechanisms of virulence functions, 2) the biogenesis of autotransporters and 3) regulation of gene expression. All three are potential sites for intervention to prevent host colonisation and infection.
PhD, physics, Strasbourg, France, 2002, polymer adsorption with the Atomic Force Microscope
Post-doctoral fellowship, Liverpool, UK, Design of peptides as capping agents for gold nanoparticles
BBSRC David Phillips Fellow, Liverpool, 2006-11, Nanoparticle-based imaging in living cells; biomimetic nanoparticles
2011- Lecturer, then Senior Lecturer, University of Liverpool
Our research focuses on nanoparticles, their structure, and applications, in particular for biological imaging both at the single molecule level and for cell tracking in animal models.
Dr. Xing Li is an Assistant Professor and Associate Consultant in the Division of Biomedical Statistics and Informatics, Department of Health Science Research at Mayo Clinic - voted the best hospital by U.S. News & World Report. Dr. Li completed his PhD in Bioinformatics from The University of Michigan at Ann Arbor, Michigan, USA. Dr. Li also holds a Masters Degree in Biochemistry and Molecular Biology and Bachelors Degree in Microbiology. Dr. Li’s research interests focus on machine learning, bioinformatics, and statistical data mining in large scale data in biomedical research, such as next generation sequencing data (whole genome sequencing, RNA-seq, microarray data), in the file. He has published more than 20 peer-reviewed papers in reputable journals and book chapters in the fields of Bioinformatics and Biostatistics, cancer research, cardiovascular disease, embryonic stem cell (ESC) and induced pluripotent stem cell (iPSC) research, and human genomics, genetics and development, and Microbiology. Dr. Li’s publications have been highlighted as Journal Cover Stories, Journal Featured Articles, Highlights Section Papers, Must Read by Faculty 1000, and ESC & iPSC News, etc. Dr. Li has been developing data analysis tools, such as RCircle and PCA3d, etc. Dr. Li is also a member of American Association for Cancer Research (AACR), International Society for Computational Biology (ISCB), American Statistics Association (ASA) and American Heart Association (AHA).
Prof. Rafael Lira Saade is a Mexican botanist specializing in plant systematics, ethnobotany, and phytogeography. He earned his undergraduate degree in biology from the National Autonomous University of Mexico (UNAM), with a thesis on the pteridological flora of the Sierra de Santa Marta in Los Tuxtlas, Veracruz. He pursued his master’s studies at the Instituto Nacional de Investigaciones Sobre Recursos Bióticos (INIREB), focusing on the taxonomy and ethnobotany of the Cucurbitaceae family in the Yucatán Peninsula. Lira Saade later completed his PhD at UNAM with a dissertation on the taxonomy of the genus Sechium P. Br. (Cucurbitaceae).
Currently, he is a full-time professor (titular 'B') at UNAM's Facultad de Estudios Superiores Iztacala. His research centers on the demography of useful plants and has resulted in the publication of over 60 scientific articles, 7 books, and 10 book chapters. A dedicated mentor, he has supervised numerous undergraduate and postgraduate theses.
Dr. Dongliang Liu is a Postdoctoral Associate in the Department of Surgery at the Baylor College of Medicine. His research interests include: Cancer therapy, especially for pancreatic cancer immunotherapy; Chimeric virus-like particles (VLP) vaccine, especially for cancer vaccines; Novel antibiotics development including antimicrobial peptides; Epitomics and multi-epitope peptide vaccine development for pathogenic viruses.